volume identical to dose of test product, GL0034 1mg/ml, 0.6ml per vial, GL0034 1 mg/ml, 1 ml per vial clinical trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly s.c. Administered GL0034 in Adults with Type 2 Diabetes Mellitus Inadequately controlled on Metformin Or Diet and Exercise

This study is testing a new weekly medicine, GL0034, for adults with type 2 diabetes whose blood sugar isn't well controlled by metformin or healthy living. We want to see how well it works, if it's safe, and particularly how it affects tummy issues.